Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs

Cardiovascular Research

Volumn 69, Issue 4, 2006, Pages 865-875

  Shiroshita Takeshita, Akiko ^a   Brundel, Bianca J J M ^a,c   Lavoie, Joel ^a   Nattel, Stanley ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Antiarrhythmic agents; Arrhythmia (mechanisms); Infection inflammation; Remodeling

Indexed keywords

ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; CALCINEURIN INHIBITOR; CYCLOSPORIN; IBUPROFEN; NITRIC OXIDE SYNTHASE; PREDNISONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; LOW DRUG DOSE; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA; WESTERN BLOTTING;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATRIAL FIBRILLATION; ATRIAL FUNCTION; C-REACTIVE PROTEIN; CALCINEURIN; CARDIAC PACING, ARTIFICIAL; CYCLOSPORINE; DOGS; ELECTROCARDIOGRAPHY; HEART ATRIA; IBUPROFEN; NITRIC OXIDE SYNTHASE TYPE III; PREDNISONE; TACHYCARDIA;

EID: 32444437597     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.11.028     Document Type: Article

References (45)

1. S. Nattel Therapeutic implications of atrial fibrillation mechanisms: can mechanistic insights be used to improve AF management? Cardiovasc Res 54 2002 347 360
2. P. Bruins, H. te Velthuis, A.P. Yazdanbakhsh, P.G. Jansen, F.W. van Hardevelt, and E.M. de Beaumont Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia Circulation 96 1997 3542 3548
3. A. Frustaci, C. Chimenti, F. Bellocci, E. Morgante, M.A. Russo, and A. Maseri Histological substrate of atrial biopsies in patients with lone atrial fibrillation Circulation 96 1997 1180 1184
4. M.K. Chung, D.O. Martin, D. Sprecher, O. Wazni, A. Kanderian, and C.A. Carnes C-reactive protein elevation in patients with atrial arrhythmias. Inflammatory mechanisms and persistence of atrial fibrillation Circulation 104 2001 2886 2891
5. R.J. Aviles, D.O. Martin, C. Apperson-Hansen, P.L. Houghtaling, P. Rautaharju, and R.A. Kronmal Inflammation as a risk factor for atrial fibrillation Circulation 108 2003 3006 3010
6. J. Dernellis, and M. Panaretou Relationship between C-reactive protein concentration during glucocorticoid therapy and recurrent atrial fibrillation Eur Heart J 25 2004 1100 1107
7. M.C. Wijffels, C.J. Kirchhof, R. Dorland, and M.A. Allessie Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats Circulation 92 1995 1954 1968
8. C.A. Morillo, G.J. Klein, D.L. Jones, and C.M. Guiraudon Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation Circulation 91 1995 1588 1595
9. A. Elvan, K. Wylie, and D.P. Zipes Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs. Electrophysiological remodeling Circulation 94 1996 2953 2960
10. R. Gaspo, R.F. Bosch, M. Talajic, and S. Nattel Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model Circulation 96 1997 4027 4035
11. K. Shinagawa, A. Shiroshita-Takeshita, G. Schram, and S. Nattel Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone Circulation 107 2003 1440 1446
12. A. Shiroshita-Takeshita, G. Schram, J. Lavoie, and S. Nattel Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs Circulation 110 2004 2313 2319
13. C.C. Lin, J.L. Lin, C.S. Lin, M.C. Tsai, M.J. Su, and L.P. Lai Activation of the calcineurin-nuclear activated T-cell signal transduction pathway in atrial fibrillation Chest 126 2004 1926 1932
14. H. Yan, J.Z. Chen, J.H. Zhu, Y.M. Ni, G.W. Yu, and S.J. Hu Expression of connexin in atrium of patients with atrial fibrillation and its signal transduction pathway Zhonghua Yi Xue Za Zhi 84 2004 209 213
15. B.J. Brundel, I.C. van Gelder, R.H. Henning, A.E. Tuinenburg, L.E. Deelman, and R.G. Tieleman Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation Cardiovasc Res 42 1999 443 454
16. H. Blain, C. Boileau, F. Lapicque, E. Nédélec, D. Lœuille, and C. Guillaume Limitation of the in vitro whole blood assay for predicting the COX selectivity of NSAIDs in clinical use Br J Clin Pharmacol 53 2002 255 265
17. N. Perico, P. Ruggenenti, E. Gotti, F. Gaspari, D. Cattaneo, and U. Valente Study Investigators. In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: insights from the MY.S.S. trial Kidney Int 65 2004 1084 1090
18. J. Ausma, G.D. Dispersyn, H. Duimel, F. Thone, L. VerDonck, and M.A. Allessie Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation J Mol Cell Cardiol 32 2000 355 364
19. H. Sun, D. Chartier, N. Leblanc, and S. Nattel Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes Cardiovasc Res 49 2001 751 761
20. L. Yue, J. Feng, R. Gaspo, G.R. Li, Z. Wang, and S. Nattel Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation Circ Res 81 1997 512 525
21. D. Dobrev, and U. Ravens Remodeling of cardiomyocyte ion channels in human atrial fibrillation Basic Res Cardiol 98 2003 137 148
22. A. Goette, U. Lendeckel, and H.U. Klein Signal transduction systems and atrial fibrillation Cardiovasc Res 54 2002 247 258
23. B.J. Brundel, R.H. Henning, H.H. Kampinga, I.C. VanGelder, and H.J. Crijns Molecular mechanisms of remodeling in human atrial fibrillation Cardiovasc Res 54 2002 315 324
24. M. Allessie, J. Ausma, and U. Schotten Electrical, contractile and structural remodeling during atrial fibrillation Cardiovasc Res 54 2002 230 246
25. S.H. Lee, W.C. Yu, J.J. Cheng, C.R. Hung, Y.A. Ding, and M.S. Chang Effect of verapamil in long-term tachycardia-induced atrial electrical remodeling Circulation 101 2000 200 206
26. S. Fareh, A. Bénardeau, and S. Nattel Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs Cardiovasc Res 49 2001 762 770
27. +-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling Cardiovasc Res 54 2002 438 446
28. 2+ channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs Circulation 100 1999 2191 2197
29. K. Kumagai, H. Nakashima, and K. Saku The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model Cardiovasc Res 62 2004 105 111
30. A. Frustaci, M. Caldarulo, A. Buffon, F. Bellocci, R. Fenici, and D. Melina Cardiac biopsy in patients with "primary" atrial fibrillation. Histologic evidence of occult myocardial diseases Chest 100 1991 303 306
31. B. Lo, R. Fijnheer, A.P. Nierich, P. Bruins, and C.J. Kalkman C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization Ann Thorac Surg 79 2005 1530 1535
32. C.J. Menkes Effects of disease-modifying anti-rheumatic drugs, steroids and non-steroidal anti-inflammatory drugs on acute-phase proteins in rheumatoid arthritis Br J Rheumatol 32 Suppl. 3 1993 14 18
33. Y. Amano, S.W. Lee, and A.C. Allison Inhibition by glucocorticoids of the formation of interleukin-1α, interleukin-1β, and interleukin-6: mediation by decreased mRNA stability Mol Pharmacol 43 1993 176 182
34. A.C.B. Cato, and E. Wade Molecular mechanisms of anti-inflammatory action of glucocorticoids Bioessays 18 1996 371 378
35. Y. Ishii, R.B. Schuessler, S.L. Gaynor, K. Yamada, A.S. Fu, and J.P. Boineau Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation Circulation 111 2005 2881 2888
36. K.D. Kroncke Nitrosative stress and transcription Biol Chem 384 2003 1365 1377
37. L.A. Barouch, R.W. Harrison, M.W. Skaf, G.O. Rosas, T.P. Cappola, and Z.A. Kobeissi Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms Nature 416 2002 337 339
38. S.C. Schafer, T. Wallerath, E.I. Closs, C. Schmidt, P.M. Schwarz, and U. Forstermann Dexamethasone suppresses eNOS and CAT-1 and induces oxidative stress in mouse resistance arterioles Am J Physiol Heart Circ Physiol 288 2005 H436 H444
39. H. Cai, Z. Li, A. Goette, F. Mera, C. Honeycutt, and K. Feterik Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke Circulation 106 2002 2854 2858
40. C.A. Carnes, M.K. Chung, T. Nakayama, H. Nakayama, R.S. Baliga, and S. Piao Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation Circ Res 89 2001 e32 e38
41. M.J. Mihm, F. Yu, C.A. Carnes, P.J. Reiser, P.M. McCarthy, and D.R. Van Wagoner Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation Circulation 104 2001 174 180
42. S.C. Dudley, E. Hoch, L.A. McCann, C. Honeycutt, L. Diamandopoulus, and T. Fukai Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage. Role of the NADPH and xanthine oxidase Circulation 112 2005 1266 1273
43. Y.M. Kim, T.J. Guzik, Y.H. Zhang, M.H. Zhang, H. Kattach, and C. Ratnatunga A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation Circ Res 97 2005 629 636
44. N. Leonard, A.E. Bishop, J.M. Polak, and I.C. Talbot Expression of nitric oxide synthase in inflammatory bowel disease is not affected by corticosteroid treatment J Clin Pathol 51 1998 750 753
45. D. Bouchard, M.A. Despatis, J. Buluran, and R. Cartier Vascular effects of cyclosporin A and acute rejection in canine heart transplantation Ann Thorac Surg 64 1997 1325 1330